News & Updates

Treatment with the thyroid hormone receptor β agonist ALG-055009 appears to yield substantial reductions in liver fat with no relevant safety issues in patients with metabolic dysfunction-associated steatohepatitis (MASH), according to a phase IIa study.

Supplementation with high-dose folic acid appears beneficial to pregnant women with epilepsy being treated with antiseizure medications (ASMs), having been associated with a lower incidence of adverse offspring outcomes in an observational study from China.

A natural language processing-pretrained large language model (LLM) has shown its capabilities for few-shot lung cancer classification in a real-world mixed clinical cohort using electronic nose (eNose) breathprints, resulting in lesser dependence on large training datasets, according to a study.

A clinical decision support tool that uses artificial intelligence has shown success in predicting hip fracture in adults, serving as a potential resource-efficient solution for population screening, according to a nationwide cohort study.

Knee radiographs can be used to identify individuals at increased risk for the development of knee osteoarthritis (OA) symptoms, suggests a study.

Sleep disturbances during perimenopause are associated with poorer cognitive function decades later, as suggested in a study.

Children born to mothers with mild or asymptomatic COVID-19 during pregnancy are not at increased risk of neurodevelopmental delay in early life, according a study from Singapore.

Glycosylated noncoding small RNAs (glycoRNAs) are present in human hepatocytes and liver tissues, showing a dysregulated expression in experimental steatosis models and in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), a study has found.

Treatment with bulevirtide monotherapy for up to 144 weeks is safe, well tolerated, and effective in patients with chronic hepatitis D (CHD), a study has shown.